Skip to main content
. Author manuscript; available in PMC: 2009 Mar 18.
Published in final edited form as: Eur J Pharmacol. 2007 Mar 30;566(1-3):58–66. doi: 10.1016/j.ejphar.2007.03.037

Fig. 2.

Fig. 2

Experimental protocols for cell viability assay in ischemia/reperfusion injury. Using an established chick cardiomyocyte model of simulated ischemia/reperfusion, tested flavonoids were: incubated since 72 h before ischemia and continued through ischemia/reperfusion (chronic treatment), treated during ischemia and reperfusion (ischemia/reperfusion treatment), or administered at reperfusion only (reperfusion treatment).